Results 101 to 110 of about 728 (161)

Cardiac myosin inhibitors for hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Hasana U, Korpal M, Haider F, Umer M, Lwin NPT, Iqbal S, Kumar R, Ahsan M, Hassan E, Ullah W, Khalid S, Gupta A, Alsubari AMA, Ehsan M, Ahmad A.   +14 more
europepmc   +1 more source

Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis. [PDF]

Eur Heart J Cardiovasc Pharmacother
Awad K, Pereyra Pietri M, Farina JM, Pathangey G, Abbas MT, Scalia IG, Le Couteur D, Wilanksy S, Lester SJ, Ommen SR, Geske JB, Arsanjani R, Ayoub C.   +12 more
europepmc   +1 more source

Cardiac myosin inhibitors: a silver lining for an old disease. [PDF]

Open Heart
Yadav S, Agstam S, Singh S.
europepmc   +1 more source

The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review. [PDF]

Heart Fail Rev
Othman L, Koskina L, Huerta N, Rao SJ.
europepmc   +1 more source

CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy. [PDF]

Eur J Clin Pharmacol
Kasolo Y, Burford E, Obeidat M, Beaman GM, Monk T, Bastiaenen R, Newman WG, Cooper RM.   +7 more
europepmc   +1 more source

Hypertrophic Cardiomyopathy and Phenocopies: New Therapies for Old Diseases-Current Evidence and Future Perspectives. [PDF]

J Clin Med
Alfarano M, Ciccarelli F, Marchionni G, Ballatore F, Costantino J, Lattanzio A, Pecci G, Stavagna S, Iannelli L, Galardo G, Lavalle C, Miraldi F, Vizza CD, Chimenti C.   +13 more
europepmc   +1 more source

Hypertrophic cardiomyopathy evolving management: American Heart Association/American College of Cardiology vs. European Society of Cardiology guidelines [PDF]

Olivotto, Iacopo
core   +1 more source

Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy. [PDF]

J Am Heart Assoc
Dybro AM, Rasmussen TB, Nielsen RR, Ladefoged BT, Pedersen ALD, Terkelsen CJ, Andersen MJ, Jensen MK, Poulsen SH.   +8 more
europepmc   +1 more source

Coexistence of Hypertrophic Cardiomyopathy and Arterial Hypertension: Current Insights and Future Directions. [PDF]

Diseases
Katsi V, Papadomarkaki K, Manousiadis K, Triantafyllou E, Fragoulis C, Tsioufis K.   +5 more
europepmc   +1 more source